Andreas Halvorsen acquired 2.67M Oruka Therapeutics shares worth $160M. That's 0.41% of their equity portfolio (58th largest holding). The investor owns 7.12% of the outstanding Oruka Therapeutics stock. The stake costed the investor $39.4M, netting the investor a gain of 307% so far.